PUM1
OFFICE ACTION ISSUED POU1
20/05/2026
Voltar para busca
Dado oficial do USPTO
TURN THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TURN THERAPEUTICS
ST13
US500000088044977Classe
5, 42
Pedido
88044977
Registro
6283602
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
21/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
19/07/2018
Data de registro
02/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/03/2021
Última transação
21/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/07/2019
Primeiro uso no comércio
31/07/2019
Código do desenho
4
Tipo de titular
03
Localização do titular
Calabasas, CA, US
Examinador
GILLES, DEBORAH LYNN MEINERS
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
GLOBAL HEALTH SOLUTIONS, INC.
Global Health Solutions LLC
Global Health Solutions LLC
Representantes
Turn Therapeutics Inc.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsantivirals; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposesfor infectious diseases; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes
Classe 42
Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/05/2026
ES8R
TEAS SECTION 8 RECEIVED
24/04/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/01/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
27/01/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
27/01/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/01/2021
IUAF
USE AMENDMENT FILED
06/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/01/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/07/2020
EX3G
SOU EXTENSION 3 GRANTED
08/07/2020
EXT3
SOU EXTENSION 3 FILED
08/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/01/2020
EX2G
SOU EXTENSION 2 GRANTED
02/01/2020
EXT2
SOU EXTENSION 2 FILED
02/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/07/2019
EX1G
SOU EXTENSION 1 GRANTED
05/07/2019
EXT1
SOU EXTENSION 1 FILED
05/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/03/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/03/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/11/2018
PUBO
PUBLISHED FOR OPPOSITION
13/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/10/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/10/2018
ALIE
ASSIGNED TO LIE
08/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/09/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
22/09/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/09/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
22/09/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/09/2018
DOCK
ASSIGNED TO EXAMINER
21/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/07/2018
NWAP
NEW APPLICATION ENTERED
23/07/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TURN THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.